David Arthur Berry
75Patents
19h-index
95Co-inventors
83Inventor score
Filing activity: Jun 29, 2005 → Jan 26, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9028841B2 | Synergistic bacterial compositions and methods of production and use thereof | Emerging Cross-Sectional Technologies | 235 | Active |
| US9011834B1 | Compositions and methods | Emerging Cross-Sectional Technologies | 234 | Active |
| US8906668B2 | Synergistic bacterial compositions and methods of production and use thereof | Emerging Cross-Sectional Technologies | 132 | Active |
| US9610307B2 | Probiotic compositions containing clostridiales for inhibiting inflammation | Emerging Cross-Sectional Technologies | 113 | Active |
| US9180147B2 | Compositions and methods | Emerging Cross-Sectional Technologies | 88 | Active |
| US9446080B2 | Compositions and methods | Emerging Cross-Sectional Technologies | 79 | Active |
| US9533014B2 | Synergistic bacterial compositions and methods of production and use thereof | Emerging Cross-Sectional Technologies | 75 | Active |
| US9585921B2 | Compositions and methods | Emerging Cross-Sectional Technologies | 44 | Active |
| US9603878B2 | Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease | Emerging Cross-Sectional Technologies | 39 | Active |
| US7981647B2 | Engineered CO2 fixing microorganisms producing carbon-based products of interest | Emerging Cross-Sectional Technologies | 36 | Active |
| US9644180B2 | Synthetic membrane-receiver complexes | Emerging Cross-Sectional Technologies | 35 | Active |
| US9700071B2 | Nutritive fragments, proteins and methods | Human Necessities | 34 | Active |
| US8809259B2 | Charged nutritive proteins and methods | Emerging Cross-Sectional Technologies | 26 | Active |
| US9855303B2 | Compositions and methods | Emerging Cross-Sectional Technologies | 25 | Active |
| US10076546B2 | Network-based microbial compositions and methods | Human Necessities | 20 | Active |
| US8822412B2 | Charged nutritive proteins and methods | Emerging Cross-Sectional Technologies | 19 | Active |
| US9878004B2 | Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof | Physics | 19 | Active |
| US10864235B2 | Synergistic bacterial compositions and methods of production and use thereof | Emerging Cross-Sectional Technologies | 19 | Active |
| US10064900B2 | Methods of populating a gastrointestinal tract | Emerging Cross-Sectional Technologies | 19 | Active |
| US10064901B2 | Compositions and methods | Emerging Cross-Sectional Technologies | 18 | Active |
| US10329531B2 | Synthetic membrane-receiver complexes | Emerging Cross-Sectional Technologies | 16 | Active |
| US9605040B2 | Nutritive proteins and methods | Human Necessities | 15 | Active |
| US10253296B2 | Synthetic membrane-receiver complexes | Emerging Cross-Sectional Technologies | 15 | Active |
| US10238617B2 | Amino acid compositions and methods for the treatment of liver diseases | Human Necessities | 14 | Active |
| US7785861B2 | Hyperphotosynthetic organisms | Emerging Cross-Sectional Technologies | 13 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.